{"id":"https://openalex.org/W1574435394","doi":null,"title":"Interferon-beta (INF-beta) antibodies in interferon-beta1a- and interferon-beta1b-treated multiple sclerosis patients. Prevalence, kinetics, cross-reactivity, and factors enhancing interferon-beta immunogenicity in vivo.","display_name":"Interferon-beta (INF-beta) antibodies in interferon-beta1a- and interferon-beta1b-treated multiple sclerosis patients. Prevalence, kinetics, cross-reactivity, and factors enhancing interferon-beta immunogenicity in vivo.","publication_year":2001,"publication_date":"2001-03-01","ids":{"openalex":"https://openalex.org/W1574435394","mag":"1574435394","pmid":"https://pubmed.ncbi.nlm.nih.gov/11282547"},"language":"en","primary_location":{"id":"pmid:11282547","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11282547","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European cytokine network","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004972733","display_name":"Pietro de Perini","orcid":"https://orcid.org/0000-0001-8101-0048","observed_orcids":["https://orcid.org/0000-0001-8101-0048"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Perini","raw_affiliation_strings":["Department of Neurological & Psychiatrical Sciences, Second Neurological Clinic, Geriatric Hospital, Via E. Vendramini 7, 35137 Padova, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurological & Psychiatrical Sciences, Second Neurological Clinic, Geriatric Hospital, Via E. Vendramini 7, 35137 Padova, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035385083","display_name":"Antonella Facchinetti","orcid":"https://orcid.org/0000-0002-5628-5899","observed_orcids":["https://orcid.org/0000-0002-5628-5899"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Facchinetti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029318642","display_name":"Pietro Bulian","orcid":"https://orcid.org/0000-0002-9451-0559","observed_orcids":["https://orcid.org/0000-0002-9451-0559"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Bulian","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048311214","display_name":"Angelo R. Massaro","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A R Massaro","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012064028","display_name":"D. de Pascalis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D D Pascalis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011959155","display_name":"Antonio Bertolotto","orcid":"https://orcid.org/0000-0002-7052-1907","observed_orcids":["https://orcid.org/0000-0002-7052-1907"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Bertolotto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010236510","display_name":"Giovanni Biasi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G Biasi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"P Gallo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Gallo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.5698,"has_fulltext":false,"cited_by_count":94,"citation_normalized_percentile":{"value":0.94561254,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"12","issue":"1","first_page":"56","last_page":"61"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.8109999895095825},{"id":"https://openalex.org/keywords/relapsing-remitting-multiple-sclerosis","display_name":"relapsing-remitting multiple sclerosis","score":0.9580000042915344},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.8379999995231628},{"id":"https://openalex.org/keywords/route-of-administration","display_name":"route of administration","score":0.9340000152587891},{"id":"https://openalex.org/keywords/intramuscular-injection","display_name":"intramuscular injection","score":0.7839999794960022},{"id":"https://openalex.org/keywords/subcutaneous-injection","display_name":"subcutaneous injection","score":0.9860000014305115},{"id":"https://openalex.org/keywords/dosing-frequency","display_name":"dosing frequency","score":0.6949999928474426},{"id":"https://openalex.org/keywords/antibody-kinetics","display_name":"antibody kinetics","score":0.6970000267028809},{"id":"https://openalex.org/keywords/cross-reactivity","display_name":"cross-reactivity","score":0.8730000257492065},{"id":"https://openalex.org/keywords/washout-period","display_name":"washout period","score":0.8450000286102295},{"id":"https://openalex.org/keywords/avonex","display_name":"Avonex","score":0.8330000042915344},{"id":"https://openalex.org/keywords/interferon-beta-1b","display_name":"interferon beta-1b","score":0.906000018119812},{"id":"https://openalex.org/keywords/rebif","display_name":"Rebif","score":0.9929999709129333},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.39899998903274536}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8315682411193848},{"id":"https://openalex.org/C2908698914","wikidata":"https://www.wikidata.org/wiki/Q2450337","display_name":"Interferon beta-1a","level":4,"score":0.731881856918335},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.6254485845565796},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.5749683976173401},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5507225394248962},{"id":"https://openalex.org/C2776174256","wikidata":"https://www.wikidata.org/wiki/Q830842","display_name":"BETA (programming language)","level":2,"score":0.5334793329238892},{"id":"https://openalex.org/C2910198813","wikidata":"https://www.wikidata.org/wiki/Q1851162","display_name":"Interferon beta-1b","level":4,"score":0.5161429643630981},{"id":"https://openalex.org/C32611913","wikidata":"https://www.wikidata.org/wiki/Q2166189","display_name":"Titer","level":3,"score":0.4824110269546509},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.47583484649658203},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.44210296869277954},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.41236191987991333},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3963415026664734},{"id":"https://openalex.org/C2994247566","wikidata":"https://www.wikidata.org/wiki/Q2450337","display_name":"Interferon beta","level":3,"score":0.3091953992843628},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000068556","descriptor_name":"Interferon beta-1a","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000068556","descriptor_name":"Interferon beta-1a","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000068556","descriptor_name":"Interferon beta-1a","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000068576","descriptor_name":"Interferon beta-1b","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000068576","descriptor_name":"Interferon beta-1b","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000068576","descriptor_name":"Interferon beta-1b","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000906","descriptor_name":"Antibodies","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000906","descriptor_name":"Antibodies","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000906","descriptor_name":"Antibodies","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003429","descriptor_name":"Cross Reactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003429","descriptor_name":"Cross Reactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003429","descriptor_name":"Cross Reactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016899","descriptor_name":"Interferon-beta","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016899","descriptor_name":"Interferon-beta","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016899","descriptor_name":"Interferon-beta","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016899","descriptor_name":"Interferon-beta","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016899","descriptor_name":"Interferon-beta","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016899","descriptor_name":"Interferon-beta","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false}],"locations_count":3,"locations":[{"id":"pmid:11282547","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11282547","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European cytokine network","raw_type":"Journal Article"},{"id":"pmh:oai:www.research.unipd.it:11577/2504241","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11577/2504241","pdf_url":null,"source":{"id":"https://openalex.org/S4306402547","display_name":"Padua Research Archive (University of Padova)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I138689650","host_organization_name":"University of Padua","host_organization_lineage":["https://openalex.org/I138689650"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"mag:1574435394","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11282547","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.7300000190734863}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2404984438","https://openalex.org/W2411074299","https://openalex.org/W2033185577","https://openalex.org/W2026112786","https://openalex.org/W1998213772","https://openalex.org/W249021389","https://openalex.org/W2054776967","https://openalex.org/W2474376295","https://openalex.org/W2021850497","https://openalex.org/W2030042113"],"abstract_inverted_index":{"We":[0],"analysed":[1],"the":[2,130,191,198,215,219,225,233,238,266,278,282],"role":[3],"of":[4,9,11,25,42,45,53,65,73,76,87,90,137,195,208,227,232,235,242,281],"dosage,":[5,239],"route":[6,234],"and":[7,83,132,155,184,237,246],"frequency":[8],"administration":[10,194,236],"clinical":[12,279],"grade":[13],"interferon-beta":[14],"(IFN-beta)":[15],"preparations":[16],"in":[17,22,165,274],"inducing":[18],"anti-IFN-beta":[19],"antibodies":[20],"(IFN-beta-Abs)":[21],"5":[23],"groups":[24],"relapsing-remitting":[26],"multiple":[27],"sclerosis":[28],"(RRMS)":[29],"patients":[30,140,167],"who":[31],"were":[32,97,168],"respectively":[33],"treated":[34,141,174],"as":[35],"follows:":[36],"1)":[37],"weekly":[38,62,123,193],"intramuscular":[39],"(i.m.)":[40],"injections":[41,52,64,72,86],"30":[43],"mg":[44,55,67,75,89],"recombinant":[46],"IFN-beta1a":[47,77,91,106,179,196,228,273],"(Avonex),":[48],"2)":[49],"subcutis":[50],"(s.c.)":[51],"250":[54,66],"IFN-beta1b":[56,68,101,243,271],"(Betaferon)":[57],"every":[58,112],"other":[59,113],"day,":[60,114],"3)":[61],"i.m.":[63,85,119,125,176,192,254],"(Betaferon),":[69],"4)":[70],"s.c.":[71,111,143,178],"22":[74,88],"(Rebif)":[78,92],"three":[79,171],"times":[80],"a":[81,94,121,205,260],"week,":[82],"5)":[84],"twice":[93],"week.":[95],"IFN-beta-Abs":[96,257],"determined":[98],"by":[99,253],"ELISA.":[100],"was":[102,197,211],"more":[103],"immunogenic":[104,200],"than":[105],"not":[107,250],"only":[108,180],"when":[109,117,265],"administered":[110,118],"but":[115,158,249],"also":[116],"at":[120,186],"lower":[122,134],"dose;":[124],"injection,":[126],"however,":[127],"significantly":[128],"delayed":[129],"appearance,":[131],"induced":[133],"serum":[135],"levels":[136,146,163,217],"IFN-beta-Abs.":[138],"In":[139,202],"with":[142,175],"IFN-beta1b,":[144],"Ab":[145],"peaked":[147],"3":[148],"to":[149,161,213,272,276],"9":[150],"months":[151,210],"after":[152,170],"therapy":[153],"initiation,":[154],"then":[156,185],"slowly,":[157],"progressively,":[159],"declined":[160],"pre-therapy":[162],"that":[164,224,241],"some":[166],"reached":[169],"years.":[172],"Patients":[173],"or":[177],"rarely":[181],"developed":[182],"IFN-beta-Abs,":[183],"very":[187],"low":[188],"titers.":[189],"Overall,":[190],"less":[199],"treatment.":[201],"IFN-beta1b-treated":[203],"patients,":[204],"wash-out":[206,261],"period":[207,262],"two/three":[209],"sufficient":[212],"bring":[214],"IFN-beta-Ab":[216],"below":[218],"cut-off.":[220],"Our":[221],"findings":[222],"suggest":[223],"immunogenicity":[226],"is":[229,244,247,263,268],"low,":[230],"regardless":[231],"while":[240],"high,":[245],"significantly,":[248],"completely":[251],"reduced":[252],"administration.":[255],"As":[256],"are":[258],"cross-reactive,":[259],"suggested":[264],"preparation":[267],"changed":[269],"from":[270],"order":[275],"maintain":[277],"benefits":[280],"therapy.":[283]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":8}],"updated_date":"2026-10-10T09:11:00.788812","created_date":"2025-10-10T00:00:00"}